---
url: https://www.servicesaustralia.gov.au/short-bowel-syndrome
title: Short bowel syndrome - Health professionals - Services AustraliaServices AustraliaServices Australia
scrapedAt: 2026-02-20T21:41:49.231Z
source: servicesaustralia.gov.au
---
# Short bowel syndrome

The PBS subsidises teduglutide for patients with type III short bowel syndrome with intestinal failure.

## on this page

-   [Patient eligibility](#a1)
-   [Section 100 arrangements](#a2)
-   [Treatment specifics](#a3)
-   [Authority applications](#a4)
-   [More information](#a5)

## Patient eligibility

The Pharmaceutical Benefits Scheme (PBS) subsidises treatment with teduglutide under the _National Health Act 1953_, section 100 for patients with type III short bowel syndrome with intestinal failure.

Patients must be eligible for the [PBS](/pharmaceutical-benefits-scheme) and meet the relevant restriction criteria.

The [Schedule of Pharmaceutical Benefits](http://www.pbs.gov.au/pbs/home;jsessionid=jrrab7f28xtjycras12yiccu) on the PBS website outlines the restrictions for prescribing teduglutide.

## Section 100 arrangements

### Teduglutide

This item is only PBS-subsidised for non-admitted patients, day admitted patients, or patients on discharge who are attending:

-   an approved private hospital
-   a public hospital.

This item isn’t PBS-subsidised for public hospital in-patients. You must include the hospital name and provider number on the authority application form.

## Treatment specifics

To be eligible for PBS-subsidised treatment with teduglutide, patients must be treated by a gastroenterologist or by a specialist within a multidisciplinary intestinal rehabilitation unit.

## Authority applications

### Applying for initial treatment

Please note: You don’t need to complete this application in writing when you request [PBS authority online](/apply-for-pbs-authority?context=20).

Applications for initial authority approval to prescribe PBS-subsidised teduglutide to treat short bowel syndrome can be made either:

-   using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   in writing and use [HPOS Form upload](/hpos?context=20)
-   in writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [short bowel syndrome with intestinal failure - teduglutide - initial authority application form](/pb275?context=20)
-   relevant attachments.

### Applying for continuing treatment

Please note: You don’t need to complete this application in writing when you request [PBS authority online](/apply-for-pbs-authority?context=20).

Applications for continuing authority approval to prescribe PBS-subsidised teduglutide to treat short bowel syndrome can be made either:

-   using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   in writing and use [HPOS Form upload](/hpos?context=20)
-   in writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [short bowel syndrome with intestinal failure - teduglutide - continuing authority application form](/pb276?context=20)
-   relevant attachments.

## More information

Call the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs) for more information.
